abstract |
The present invention relates to a novel drug effective for treating cancer containing double-stranded RNA such as poly (I) poly (C). Specifically, the present invention provides a carrier prepared from 2-0- (2-diethylaminoethyl) carbamoyl-1,3-0-dioleoylglycerol, and a phospholipid as a main component, and a poly (I) -poly ( C) or a nuclease activator in cancer cells containing a complex with mismatched poly (I) -poly (C). |